Physician profile
Gunnar Thors
NPI 1508893884
$2,211.91
in general payments reported to CMS, 2019-2025
16 companies · $418 in 2025
The $418 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $418 · 2020: $195 · 2021: $299 · 2022: $322 · 2023: $302 · 2024: $258 · 2025: $418.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $748 · Long Term Medical Supply Or Device Loan: $211 · Travel and Lodging: $18.58.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $747.77 |
| Long Term Medical Supply Or Device Loan | $211.31 |
| Travel and Lodging | $18.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $819.46 | 2019-2022 | |
| Abbvie INC. | $502.85 | 2023-2025 | Botox |
| Integra Lifesciences Corporation | $261.24 | 2024-2025 | Durasorb Monofilament Mesh, Integra, Omnigraft |
| Musculoskeletal Transplant Foundation INC. | $108.87 | 2019-2024 | |
| Mentor Worldwide LLC | $99.58 | 2019-2023 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Sientra, INC. | $99.00 | 2021-2022 | |
| Misonix INC | $56.97 | 2019-2020 | |
| Motiva USA, LLC | $53.57 | 2025 | |
| Kci USA, INC. | $46.42 | 2019-2023 | Prevena Restor Bellaform, Prevena |
| Kerecis Limited | $35.42 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Tela Bio, INC. | $29.76 | 2022 | |
| Galderma Laboratories, L.P. | $27.32 | 2019-2020 | |
| Davol INC. | $21.01 | 2024 | |
| Tempus Ai, INC | $20.69 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $16.07 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acell, INC. | $13.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gunnar Thors listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.